Treatment of Residual Myopic Refraction After 6 Months on Pseudophakic Patients Using Relex-Smile | MicrobiomeTrials← Back to trialsNCT04693663
Treatment of Residual Myopic Refraction After 6 Months on Pseudophakic Patients Using Relex-Smile
ENROLLING_BY_INVITATIONNAINTERVENTIONAL
Trial Details
Start: 2017-06-01Est. Completion: 2018-06-01
Enrollment target: 20 participants Locations- Eye Hospital Pristina, Pristina, Kosovo
Other microbiome trials you might be interested in
PseudophakiaMyopiaHyperopia
Successful treatment of residual refraction 6 months after IOL Implantation with Relex-Smile.
Pristina, KosovoCompleted Jun 1, 2018
PseudophakiaHypermetropiaMyopia
The residual hypermetropic refraction on pseudophakic(Trifocal IOL) patients is difficult to treat surgically. In additi…
Pristina, KosovoEst. completion Apr 1, 2020